Transdermally Administered Scopolamine vs. Dimenhydrinate: I.Effect on Nausea and Vertigo in Experimentally Induced Motion Sickness
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
The effect of transdermally administered scopolamine (TTS-scopolamine) (2.5 cm2 surface area, one and two patches) and dimenhydrinate (100 mg) on experimental motion sickness was examined in 16 healthy volunteers in a randomized double-blind study. Nausea was induced by Coriolis manoeuvre and vertigo by calorization of the ear. In all subjects, scopolamine was found in urine in concentrations indicating adequate absorption of the drug. One TTS-scopolamine, two TTS-scopolamine and dimenhydrinate caused a statistically significant reduction in nausea when compared with placebo. Dimenhydrinate was somewhat more effective against nausea than one TTS-scopolamine. Vertigo was significantly reduced after dimenhydrinate and two TTS-scopolamine. Side effects of both drugs were negligible, though gait disturbances and vertigo could occur occasionally after two TTS-scopolamine. No dose-response relationship was found between the urinary excretion of scopolamine and alleviation of nausea. Dimenhydrinate and TTS-scopolamine are both effective against motion sickness, the latter provided it is applied 6 to 8 hours before exposure to the stimulus causing the motion sickness.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
(1992) · Applied Ergonomics · doi:10.1016/0003-6870(92)90318-p · Cited by 5,737
The Pharmacological Basis for Therapeutics
JOHNS, M. E. (1981) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.1981.00790410063020 · Cited by 1,993
(1968) · PubMed · Cited by 428
Money, K. E. (1970) · Physiological Reviews · doi:10.1152/physrev.1970.50.1.1 · Cited by 392
Transdermal scopolamine in the prevention of motion sickness at sea
Price, N. M., Schmitt, L. G., McGuire, J., Shaw, J. E., & Trobough, G. (1981) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1981.57 · Cited by 102
Brand, J., & Perry, W. L. (1966) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07243-6 · Cited by 95
Brand, J., & Perry, W. L. (1966) · PubMed · Cited by 71
Antimotion Sickness and Antiemetic Drugs
Wood, C. D. (1979) · Drugs · doi:10.2165/00003495-197917060-00003 · Cited by 70
Transdermal scopolamine psychosis.
Osterholm, R. K., & Camoriano, J. K. (1982) · PubMed · Cited by 41
Effect of transdermally administered scopolamine in preventing motion sickness
McCauley, M. E., Royal, J. W., Shaw, J. E., & Schmitt, L. G. (1981) · Journal of Sound and Vibration · doi:10.1016/0022-460x(81)90430-2 · Cited by 37
Research works printed but not linked: 7
- Brand J. J., 1968, Aerosp Med, 39, 999
- Brandt Th., 1974, Aerosp Med, 45, 1291
- Graybiel A., 1978, Aviat Space Environ Med, 49, 914
- Graybiel A., 1968, Aerosp Med, 39, 453
- Lehman, E. L. 1975. Non Parametric Statistical Methods Based on Ranks, pp. 123–132. Holden-Day, San Francisco.
- Money K. E., 1970, Phys Rev, 50, 1
- Wood C. D., 1966, Aerosp Med, 37, 259
Cited by
Pharmacokinetics and Pharmacodynamics in Clinical Use of Scopolamine
Renner, U. D., Oertel, R., & Kirch, W. (2005) · Therapeutic Drug Monitoring · doi:10.1097/01.ftd.0000168293.48226.57 · Cited by 314
Motion Sickness: Current Knowledge and Recent Advance.
Zhang, L., Wang, J., Qi, R., Pan, L., Li, M., & Cai, Y. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12468 · Cited by 216
Pharmacological Treatment of Vertigo
Hain, T. C., & Uddin, M. (2003) · CNS Drugs · doi:10.2165/00023210-200317020-00002 · Cited by 159
Scopolamine (hyoscine) for preventing and treating motion sickness
Spinks, A., & Wasiak, J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002851.pub4 · Cited by 152
Nachum, Z., Shupak, A., & Gordon, C. R. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645060-00001 · Cited by 139
Metadata
- Authors
- Pyykkö, I., Schalén, L., & Jäntti, V.
- Affiliations
- Lund University (SE)
- ORCID
- Pyykkö, I.
- Venue
- Acta Oto-Laryngologica
- Publisher
- Informa UK Limited
- Published
- 1985-01
- Volume
- 99
- Issue
- 5-6
- Pages
- 588-596
- ISSN
- 0001-6489 (ISSN-L)
- 1651-2251
- OpenAlex
- W2749083812
- Cited by
- 41
- References
- 21
- Citations by year
- 2024: 1 · 2022: 3 · 2020: 1 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 1 · 2014: 3 · 2013: 1 · 2012: 1
- FWCI
- 2.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Acta Oto-Laryngologica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Nausea and vomiting management
- Life Sciences › Neuroscience › Neurology › Vestibular and auditory disorders
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- scopolamine, dimenhydrinate, transdermal scopolamine, motion sickness, nausea, vertigo, urinary drug excretion, gait disturbance, antiemetic efficacy
- MeSH terms
- Adult, Delayed-Action Preparations, Dimenhydrinate, Double-Blind Method, Female, Humans, Male, Nausea, Random Allocation, Scopolamine, Vertigo
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Transdermally Administered Scopolamine vs. Dimenhydrinate: I.Effect on Nausea and Vertigo in Experimentally Induced Motion Sickness. https://app.cochat.ai/papers/10.3109/00016488509182265
- The paper
- Pyykkö, I., Schalén, L., & Jäntti, V. (1985). Transdermally Administered Scopolamine vs. Dimenhydrinate: I.Effect on Nausea and Vertigo in Experimentally Induced Motion Sickness. Acta Oto-Laryngologica. https://doi.org/10.3109/00016488509182265
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.